CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-27 | Sturmer Michael E PRESIDENT | Shares withheld for taxes | −5,807 | $30.57 | $178K | 204,513 |
| 2023-02-15 | Payson Norman Director | Gift | −8,652 | 3,480 | ||
| 2023-02-15 | Payson Norman Director | Gift | +8,652 | 281,098 | ||
| 2023-02-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +2,305 | $3.95 | $9K | 226,205 |
| 2023-02-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,305 | $35.28 | $81K | 223,900 |
| 2023-02-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −576 | $35.28 | $20K | 131,838 |
| 2023-02-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −2,305 | 1,256,515 | ||
| 2023-02-06 | Schlanger David J Executive Chairman | Exercise or conversion | +5,824 | $0.91 | $5K | 81,992 |
| 2023-02-06 | Schlanger David J Executive Chairman | Sale | −5,824 | $35.26 | $205K | 76,168 |
| 2023-02-06 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −5,824 | 925,119 | ||
| 2023-02-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 255,900 |
| 2023-02-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −30,290 | $35.52 | $1.1M | 225,610 |
| 2023-02-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,710 | $36.16 | $62K | 223,900 |
| 2023-02-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −7,575 | $35.52 | $269K | 132,839 |
| 2023-02-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −425 | $36.16 | $15K | 132,414 |
| 2023-02-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 1,258,820 | ||
| 2023-02-03 | Schlanger David J Executive Chairman | Exercise or conversion | +100,000 | $0.91 | $91K | 176,168 |
| 2023-02-03 | Schlanger David J Executive Chairman | Sale | −94,644 | $35.51 | $3.4M | 81,524 |
| 2023-02-03 | Schlanger David J Executive Chairman | Sale | −5,356 | $36.14 | $194K | 76,168 |
| 2023-02-03 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −100,000 | 930,943 |
Page 31 of 77 · 1,524 trades